A detailed history of Byrne Financial Freedom, LLC transactions in Amgen Inc stock. As of the latest transaction made, Byrne Financial Freedom, LLC holds 1,274 shares of AMGN stock, worth $435,338. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,274
Holding current value
$435,338
% of portfolio
0.18%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$271.18 - $309.22 $345,483 - $393,946
1,274 New
1,274 $359 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Byrne Financial Freedom, LLC Portfolio

Follow Byrne Financial Freedom, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Byrne Financial Freedom, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Byrne Financial Freedom, LLC with notifications on news.